Sulfonylureas blockade of neural and cardiac HERG channels (original) (raw)

hERG potassium channel inhibition by ivabradine requires channel gating

G. André Ng

Journal of Molecular and Cellular Cardiology, 2015

View PDFchevron_right

Effect of sulfinpyrazone on adriamycin induced acute cardiotoxic arrhythmias in rabbits

Simon Rabkin

Pharmacological research communications, 1980

View PDFchevron_right

Pharmacotherapy of Cardiac Arrhythmias-Basic Science for Clinicians

Chinmay Patel

Pacing and Clinical Electrophysiology, 2009

View PDFchevron_right

Maraula et al. Neuropharmacol. 2012

Felicita Pedata

View PDFchevron_right

Physicochemical Features of the hERG Channel Drug Binding Site

david fernandez

Journal of Biological Chemistry, 2004

View PDFchevron_right

The Electrocardiogram and Drug-Induced Arrhythmias

Bassem Chehab

Kansas Journal of Medicine, 2011

View PDFchevron_right

Drugs to Enhance or Inhibit Sinus Node Activity

Antonio Zaza

1998

View PDFchevron_right

Psychotropic medications affecting biological rhythm

Yavuz Selvi

Journal of Mood Disorders, 2011

View PDFchevron_right

COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels

Shetuan Zhang

Biophysical Journal, 2021

View PDFchevron_right

Abstracts Second Congress of the European Society for Clinical Neuropharmacology

A. Seghers

Journal of Neural Transmission, 1995

View PDFchevron_right

The potassium channel blocker, dalfampridine diminishes ouabain-induced arrhythmia in isolated rat atria

zahra Mousavi

Archives of Physiology and Biochemistry, 2018

View PDFchevron_right

Lethal Sodium Channel Antagonist Natural Neurotoxin

Anurag Pandey

View PDFchevron_right

N-Bridged bicyclic sulfonamides as inhibitors of γ-secretase

Anh Hào Trương

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists

Hubert Gstach

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Potassium Channel Toxins and Transmitter Release

Hossein Vatanpour

Annals of the New York Academy of Sciences, 1994

View PDFchevron_right

Drug treatment in heart failure

Eva Lonn

BMJ, 1998

View PDFchevron_right

Anaesthetic Action and Biochemistry

Colin Goodchild

British Journal of Anaesthesia, 2012

View PDFchevron_right

Experimental Therapeutics and Pharmacology

Minoru Fujiki

Neuro-Oncology, 2013

View PDFchevron_right

Neuropharmacological Screening and isolation of

Paul Nwafor

2012

View PDFchevron_right

Drugs used in the management of trigeminal neuralgia

Joanna M Zakrzewska

Oral Surgery Oral Medicine and Oral Pathology, 1992

View PDFchevron_right

Cardiotoxicity due to biological cancer therapy

Ivo Gabric

Cardiologia Croatica, 2017

View PDFchevron_right

Investigation of hERG1b influence on hERG channel pharmacology at physiological temperature

Dario Melgari

Journal of Pharmacology and Pharmacotherapeutics

View PDFchevron_right

Human -endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: Molecular cloning, expression and biological properties

Anne Virsolvy

Proceedings of the National Academy of Sciences, 1998

View PDFchevron_right

Atrial Fibrillation: Pharmacological Therapy

Chinmay Patel

Current Problems in Cardiology, 2011

View PDFchevron_right

Prevention of chemotherapy-induced left ventricular dysfunction

irma bisceglia

European Heart Journal Supplements, 2021

View PDFchevron_right

Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors

Jamin Boggs

Bioorganic & medicinal …, 2007

View PDFchevron_right

Ivabradine maintains sinus rhythm and reverses atrial tachycardia-induced cardiomyopathy

Abdulmohsen Almusaad

European Heart Journal Supplements, 2014

View PDFchevron_right

The search for novel antiarrhythmic strategies

Antonio Zaza

European Heart Journal, 1998

View PDFchevron_right

Inhibition of the Cardiac L-Type Calcium Channel Current by Antidepressant Drugs

Ivan Zahradnik

Journal of Pharmacology and Experimental Therapeutics, 2007

View PDFchevron_right

30ièmes Journées Franco-Belges de Pharmacochimie

Stephane BACH

Pharmaceuticals, 2016

View PDFchevron_right

Novel Targets of Sulforaphane in Primary Cardiomyocytes Identified by Proteomic Analysis

Luca Bini

PLoS ONE, 2013

View PDFchevron_right

Contemporary Drug Development in Heart Failure

Amirul Arif

Lippincott Williams & WilkinsHagerstown, MD, 2015

View PDFchevron_right

The grand challenge of discovering new cardiovascular drugs

Charles Hong

Frontiers in Drug Discovery

View PDFchevron_right

Influência do exercício físico em marcadores de cardiotoxicidade aguda, induzida pela administração de d-anfetamina, no modelo animal

Jose Alberto Duarte

Revista portuguesa de cardiologia: orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology: an official journal of the Portuguese Society of Cardiology

View PDFchevron_right

Prostanoids can modify response to electrical stimulus and 45Ca2+ exchange in isolated myocardial muscle cells

Undurti Das

Prostaglandins, Leukotrienes and Medicine, 1983

View PDFchevron_right